A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hypoglycemic Panel, Serum/Plasma
Test CodeHYPOG
Alias/See Also
19595
CPT Codes
80377
Includes
Chlorpropamide, Glimepiride, Glipizide, Glyburide, Nateglinide, Pioglitazone, Repaglinide, Rosiglitazone, Tolazamide, Tolbutamide
Preferred Specimen
1 mL serum collected in a red-top tube (no gel)
Minimum Volume
0.3 mL
Other Acceptable Specimens
Plasma collected in: Sodium fluoride/potassium oxalate (gray-top) tube
Instructions
Promptly centrifuge and separate serum or plasma into a plastic screw-capped vial using approved guidelines.
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 28 days
Frozen: 2 years
Refrigerated: 28 days
Frozen: 2 years
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received room temperature >48 hours • Polymer gel separation tube (PST) • Serum separator tube (SST)
Methodology
High Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
FDA Status
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Setup Schedule
Set up: As needed; Report Available: 5 days
Report Available
5 Days
Reference Range
See Laboratory Report
Clinical Significance
Test is for compliance or abuse monitoring.
Purpose: Clinical analysis; Diagnostic Aid, Exclusion Scree, Forensic Analysis.
Purpose: Clinical analysis; Diagnostic Aid, Exclusion Scree, Forensic Analysis.
Performing Laboratory
NMS Labs
200 Welsh Rd
Horsham, PA 19044
Last Updated: June 22, 2023